These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 16030173)

  • 21. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome.
    Miller J; Silverstein J; Shuster J; Driscoll DJ; Wagner M
    J Clin Endocrinol Metab; 2006 Feb; 91(2):413-7. PubMed ID: 16317059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.
    Grugni G; Guzzaloni G; Morabito F
    J Endocrinol Invest; 2001 May; 24(5):340-8. PubMed ID: 11407654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulated GH levels during the transition phase in Prader-Willi syndrome.
    Grugni G; Marzullo P; Delvecchio M; Iughetti L; Licenziati MR; Osimani S; Ragusa L; Salvatoni A; Sartorio A; Stagi S; Crinò A;
    J Endocrinol Invest; 2021 Jul; 44(7):1465-1474. PubMed ID: 33095904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study.
    Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4943-50. PubMed ID: 20702523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
    Colao A; di Somma C; Pivonello R; Cuocolo A; Spinelli L; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome.
    Grugni G; Guzzaloni G; Moro D; Bettio D; De Medici C; Morabito F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):769-75. PubMed ID: 9713567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences.
    Marostica E; Grugni G; De Nicolao G; Marazzi N; Crinò A; Cappa M; Sartorio A
    Growth Horm IGF Res; 2013 Dec; 23(6):261-6. PubMed ID: 24090687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children.
    Sohn YB; Kwak MJ; Kim SJ; Park SW; Kim CH; Kim MY; Kwon EK; Paik KH; Jin DK
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1371-7. PubMed ID: 20061428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment.
    Festen DA; de Weerd AW; van den Bossche RA; Joosten K; Hoeve H; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4911-5. PubMed ID: 17003096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.
    Höybye C; Hilding A; Jacobsson H; Thorén M
    Clin Endocrinol (Oxf); 2003 May; 58(5):653-61. PubMed ID: 12699450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there growth hormone deficiency in prader-willi Syndrome? Six arguments to support the presence of hypothalamic growth hormone deficiency in Prader-Willi syndrome.
    Eiholzer U; Bachmann S; l'Allemand D
    Horm Res; 2000; 53 Suppl 3():44-52. PubMed ID: 10971104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
    Colao A; Di Somma C; Cuocolo A; Spinelli L; Acampa W; Spiezia S; Rota F; Savanelli MC; Lombardi G
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5146-55. PubMed ID: 15985481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome.
    Shukur HH; Hussain-Alkhateeb L; Farholt S; Nørregaard O; Jørgensen AP; Hoybye C
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3634-e3643. PubMed ID: 33950234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
    Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome.
    Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C
    Growth Horm IGF Res; 2010 Jun; 20(3):179-84. PubMed ID: 20199883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.
    Mogul HR; Lee PD; Whitman BY; Zipf WB; Frey M; Myers S; Cahan M; Pinyerd B; Southren AL
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1238-45. PubMed ID: 18211968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.